| scholarly article | Q13442814 |
| P356 | DOI | 10.1210/JC.2006-0993 |
| P698 | PubMed publication ID | 17077133 |
| P2093 | author name string | Robert C Smallridge | |
| Vahab Fatourechi | |||
| Shon E Meek | |||
| Stefan Grebe | |||
| Melissa A Morgan | |||
| Thomas P Fox | |||
| Geoffrey S Gates | |||
| P433 | issue | 1 | |
| P921 | main subject | thyroglobulin | Q20817224 |
| thyroid cancer | Q826522 | ||
| P304 | page(s) | 82-87 | |
| P577 | publication date | 2006-10-31 | |
| P1433 | published in | The Journal of Clinical Endocrinology and Metabolism | Q3186902 |
| P1476 | title | Monitoring thyroglobulin in a sensitive immunoassay has comparable sensitivity to recombinant human tsh-stimulated thyroglobulin in follow-up of thyroid cancer patients | |
| P478 | volume | 92 |
| Q30367068 | 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer |
| Q82270844 | A low thyroglobulin level cannot be used to avoid adjuvant 131I therapy after thyroidectomy for thyroid carcinoma |
| Q33295399 | A sensitive Tg assay or rhTSH stimulated Tg: what's the best in the long-term follow-up of patients with differentiated thyroid carcinoma? |
| Q35042089 | Ability of the rhTSH stimulation test to predict relapse in patients with differentiated thyroid carcinoma, after long-term follow-up. |
| Q80799439 | An evaluation of serum thyroglobulin assays for the detection of recurrent differentiated thyroid carcinoma |
| Q51718288 | Application of post-surgical stimulated thyroglobulin for radioiodine remnant ablation selection in low-risk papillary thyroid carcinoma. |
| Q37733496 | Basal serum thyroglobulin measured by a second-generation assay is equivalent to stimulated thyroglobulin in identifying metastases in patients with differentiated thyroid cancer with low or intermediate risk of recurrence |
| Q80371149 | Can serum thyroglobulin levels predict patient outcome after treatment of differentiated thyroid carcinoma? |
| Q36924078 | Characterization of a new highly sensitive immunometric assay for thyroglobulin with reduced interference from autoantibodies |
| Q36736452 | Clinical review: improving the measurement of serum thyroglobulin with mass spectrometry |
| Q89469465 | Clinical utility of an ultrasensitive thyroglobulin assay in the follow-up of patients with differentiated thyroid cancer: can the stimulation test be avoided in patients with an intermediate recurrence risk? |
| Q46809570 | Combined metabolic and morphologic imaging in thyroid carcinoma patients with elevated serum thyroglobulin and negative cervical ultrasonography: role of 124I-PET/CT and FDG-PET. |
| Q37316042 | Comparison of Thyroglobulin Measurements Using Three Different Immunoassay Kits: A BRAMHS Tg-Plus RIA Kit, a BRAMHS hTg Sensitive Kryptor Kit, and a Beckman Coulter ACCESS Immunoassay Kit. |
| Q33677589 | Current concepts and future directions in differentiated thyroid cancer |
| Q37807460 | Does an undetectable rhTSH-stimulated Tg level 12 months after initial treatment of thyroid cancer indicate remission? |
| Q83001373 | False-negative thyroglobulin measurement in recurrent/metastatic thyroid carcinomas |
| Q87187492 | Follow-up of differentiated thyroid carcinoma |
| Q34134307 | How sensitive (second-generation) thyroglobulin measurement is changing paradigms for monitoring patients with differentiated thyroid cancer, in the absence or presence of thyroglobulin autoantibodies |
| Q36914985 | How the availability of recombinant human TSH has changed the management of patients who have thyroid cancer |
| Q35653514 | Impact of routine unilateral central neck dissection on preablative and postablative stimulated thyroglobulin levels after total thyroidectomy in papillary thyroid carcinoma |
| Q34640830 | LC-MS/MS in the Clinical Laboratory - Where to From Here? |
| Q26829349 | Management Guidelines for Children with Thyroid Nodules and Differentiated Thyroid Cancer |
| Q37082459 | Measuring thyroglobulin and thyroglobulin autoantibody in patients with differentiated thyroid cancer |
| Q42474502 | Post-operative stimulated thyroglobulin and neck ultrasound as personalized criteria for risk stratification and radioactive iodine selection in low- and intermediate-risk papillary thyroid cancer |
| Q84288742 | Prognostic value of post-thyroidectomy thyroglobulin levels in patients with differentiated thyroid cancer |
| Q37815386 | Recombinant human thyroid stimulating hormone in 2008: focus on thyroid cancer management |
| Q35843018 | Significance of metastatic lymph node ratio on stimulated thyroglobulin levels in papillary thyroid carcinoma after prophylactic unilateral central neck dissection |
| Q42485217 | The use of ultrasensitive thyroglobulin assays reduces but does not abolish the need for TSH stimulation in patients with differentiated thyroid carcinoma |
| Q33825202 | Thyroglobulin measurement using highly sensitive assays in patients with differentiated thyroid cancer: a clinical position paper |
| Q39837484 | Thyroid Cancer Recurrence in Patients Clinically Free of Disease with Undetectable or Very Low Serum Thyroglobulin Values |
| Q84723737 | Treatment and follow-up of low-risk patients with thyroid cancer |
| Q80876234 | [Annex II: thyroglobulin determination in the follow up of differentiated cancers of the thyroid vesicular structure] |
| Q80876228 | [Guidelines for the management of differentiated thyroid cancers] |
Search more.